Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Covington
Novartis
Chinese Patent Office
Baxter
Daiichi Sankyo
Federal Trade Commission
Cantor Fitzgerald
Johnson and Johnson
Accenture

Generated: August 21, 2017

DrugPatentWatch Database Preview

Piperazine citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for piperazine citrate and what is the scope of piperazine citrate patent protection?

Piperazine citrate
is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Bluline, Lannett, Luitpold, Alpharma Us Pharms, Impax Labs, Solvay, and Sanofi Aventis Us, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for piperazine citrate.

Summary for Generic Name: piperazine citrate

Tradenames:5
Patents:0
Applicants:8
NDAs:8
Drug Master File Entries: see list18
Bulk Api Vendors: see list36
Clinical Trials: see list523
Patent Applications: see list118
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:piperazine citrate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold
PIPERAZINE CITRATE
piperazine citrate
SYRUP;ORAL080671-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
PIPERAZINE CITRATE
piperazine citrate
SYRUP;ORAL080774-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
ANTEPAR
piperazine citrate
SYRUP;ORAL009102-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
PIPERAZINE CITRATE
piperazine citrate
TABLET;ORAL080874-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bluline
MULTIFUGE
piperazine citrate
SYRUP;ORAL009452-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Baxter
AstraZeneca
McKinsey
Deloitte
Chinese Patent Office
Argus Health
Medtronic
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot